Back to results
US 11,077,052 B1Granted
Selected multi-phase treatment for coronavirus respiratory infections
OwnerMalireddy S. Reddyinventor
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerMalireddy S. Reddyinventor
Estimating the term…
A multi-phase treatment of a respiratory disease in which one treatment is a lysing defense by applying inhibitory agents to respiratory passages. Application may be by nasal irrigant, oral gargling mouthwash, or smelling salt. Another treatment is an immune system suppressing defense by providing a liposome-based countermeasure to excess activity of the host immune system during COVID-19 infection. The liposome increases bio-activity of probiotics, probiotics-produced therapeutic peptides, bio-peptides, and antioxidant level in the blood with a sustained massive dose of antioxidants to counteract excess oxidation produced by excess activity of the host immune system, when administered through oral route.
A method of treating SARS-CoV-2 coronavirus infection by administering to a human subject in need thereof an effective amount of a preparation of:
A method of treating SARS-CoV-2 coronavirus infection by administering to a subject in need thereof, said subject chosen among human, dog, or cat, an effective amount of a preparation comprising:
Dependencies are inferred from the claim text.